Samantha Bowyer

1.3k total citations
47 papers, 652 citations indexed

About

Samantha Bowyer is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Samantha Bowyer has authored 47 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 18 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samantha Bowyer's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (10 papers). Samantha Bowyer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (10 papers). Samantha Bowyer collaborates with scholars based in Australia, United States and United Kingdom. Samantha Bowyer's co-authors include Michael Millward, Elin S. Gray, Paul Lorigan, Alberto Fusi, Rebecca Lee, Leslie Calapre, Anna Reid, Mel Ziman, Georgina V. Long and Grant A. McArthur and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Samantha Bowyer

41 papers receiving 641 citations

Peers

Countries citing papers authored by Samantha Bowyer

Since Specialization

Citations

This map shows the geographic impact of Samantha Bowyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samantha Bowyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samantha Bowyer more than expected).

Fields of papers citing papers by Samantha Bowyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samantha Bowyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samantha Bowyer. The network helps show where Samantha Bowyer may publish in the future.

Co-authorship network of co-authors of Samantha Bowyer

This figure shows the co-authorship network connecting the top 25 collaborators of Samantha Bowyer. A scholar is included among the top collaborators of Samantha Bowyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samantha Bowyer. Samantha Bowyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer—Real World Outcomes After Two Years of Therapy (COPILOT) 2024 ·Clinical Lung Cancer ·A Fantoni, Lydia Warburton, Benjamin Solomon, Marliese Alexander, (unknown), Lauren Brown, Inês Pires da Silva, Adnan Nagrial, (unknown), Malinda Itchins, Nick Pavlakis, Samantha Bowyer	0
2	Efficacy and safety of triplet nivolumab, relatlimab, and ipilimumab (NIVO + RELA + IPI) in advanced melanoma: Results from RELATIVITY-048. 2024 ·Journal of Clinical Oncology ·Paolo A. Ascierto, Reinhard Dummer, Caroline Gaudy‐Marqueste, Samantha Bowyer, Evan J. Lipson, Eleonora Ghisoni, Mark R. Middleton, (unknown), (unknown), (unknown), (unknown), (unknown), Georgina V. Long	15
3	P3.12D.09 Trial in Progress: A Phase Ib Study of HMBD-001, An Anti-HER3 Antibody, in Advanced Squamous Non-Small Cell Lung Cancer 2024 ·Journal of Thoracic Oncology ·(unknown), Ganessan Kichenadasse, Gary Richardson, Samantha Bowyer, Vladimir Andelkovic, Vinod Ganju, Alvin Tan, (unknown), David M. Thomas, (unknown), Konrad Paszkiewicz, Patrick Ingram, Jerome D. Boyd‐Kirkup, (unknown)	0
4	Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study 2024 ·The Medical Journal of Australia ·(unknown), Annette M. Lim, Mathias Bressel, Jenny Lee, Rahul Ladwa, Alexander Guminski, Brett Hughes, Samantha Bowyer, Karen Briscoe, S.J. Harris, (unknown), Robert Zielinski, Muhammad Alamgeer, Matteo S. Carlino, (unknown), John Park, Muhammad A. Khattak, Fiona Day, Danny Rischin	8
5	Association between Physical Activity and Reduced Mortality in Inoperable Lung Cancer 2023 ·Journal of Clinical Medicine ·Vinícius Cavalheri, (unknown), Joanne McVeigh, David Manners, Terry Boyle, Carolyn J. Peddle‐McIntyre, Rajesh Thomas, (unknown), Samantha Bowyer, (unknown), Leon Straker, Daniel A. Galvão	6
6	LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC 2023 ·JTO Clinical and Research Reports ·Marliese Alexander, (unknown), Sagun Parakh, Thomas John, Steven Kao, Adnan Nagrial, Samantha Bowyer, Lydia Warburton, Melissa M. Moore, Brett Hughes, Timothy Clay, Nick Pavlakis, Benjamin Solomon, Malinda Itchins	5
7	Sedentary Behaviour, Physical Activity, and Their Associations with Health Outcomes at the Time of Diagnosis in People with Inoperable Lung Cancer 2022 ·Journal of Clinical Medicine ·(unknown), Joanne McVeigh, David Manners, Terry Boyle, Carolyn J. Peddle‐McIntyre, Rajesh Thomas, (unknown), Samantha Bowyer, (unknown), Leon Straker, Daniel A. Galvão, Vinícius Cavalheri	2
8	Implementing DEI in Aviation Education: Coping and Addressing Mental Health Concerns 2022 ·Collegiate Aviation Review International ·(unknown), (unknown), Samantha Bowyer	0
9	Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer 2022 ·Translational Lung Cancer Research ·Emmanuel Acheampong, (unknown), Michael Morici, (unknown), Aaron B. Beasley, Samantha Bowyer, Du-Bois Asante, Chris Lomma, Weitao Lin, Michael Millward, Elin S. Gray	18
10	Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients 2022 ·Journal of Cancer Research and Clinical Oncology ·Emmanuel Acheampong, Michael Morici, (unknown), Samantha Bowyer, Du-Bois Asante, Weitao Lin, Michael Millward, Elin S. Gray, Aaron B. Beasley	2
11	Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapy 2022 ·European Journal of Cancer ·(unknown), (unknown), Leslie Calapre, Johnny Lo, Vikas Bhat, Samantha Bowyer, Michael Millward, Elin S. Gray	22
12	1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS] 2021 ·Annals of Oncology ·Andrew Haydon, Muhammad Alamgeer, Daniel Brungs, Frances A. Collichio, Nikhil I. Khushalani, (unknown), Danny Rischin, Ragini R. Kudchadkar, Wanxing Chai‐Ho, Gregory A. Daniels, Jose Lutzky, (unknown), Samantha Bowyer, Michael R. Migden, (unknown), Praveen K. Bommareddy, Shui He, Claudia Andreu‐Vieyra, (unknown), Andrew Hill	2
13	Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors 2021 ·Scientific Reports ·(unknown), Alistair Cook, Michael Millward, Alison M. McDonnell, Wee Loong Chin, (unknown), Tarek Meniawy, Samantha Bowyer	16
14	301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy 2020 ·Annals of Oncology ·(unknown), Leslie Calapre, Johnny Lo, (unknown), Samantha Bowyer, Abha Chopra, Mark Watson, Muhammad A. Khattak, Michael Millward, Elin S. Gray	1
15	Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infection 2018 ·Anti-Cancer Drugs ·Timothy Clay, Samantha Bowyer	6
16	Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy 2016 ·British Journal of Cancer ·Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, James Larkin, Grant A. McArthur, Victoria Atkinson, Michael Millward, (unknown), Stefan Diem, Sangeetha Ramanujam, Benjamin Y. Kong, Elizabeth Liniker, Alexander Guminski, Phillip Parente, Miles C. Andrews, Sagun Parakh, Jonathan Cebon, Georgina V. Long, Matteo S. Carlino, Oliver Klein	92
17	Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment 2015 ·Journal of Investigative Dermatology ·Elin S. Gray, Anna Reid, Samantha Bowyer, Leslie Calapre, Kelvin Shenq Woei Siew, Robert Pearce, Lester Cowell, Markus H. Frank, Michael Millward, Mel Ziman	64
18	Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer 2015 ·Lung Cancer ·M. Howell, Rebecca Lee, Samantha Bowyer, Alberto Fusi, Paul Lorigan	40
19	Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma 2014 ·Melanoma Research ·Samantha Bowyer, Aparna D. Rao, Megan Lyle, Shahneen Sandhu, Georgina V. Long, Grant A. McArthur, Jeanette Raleigh, Rodney J. Hicks, Michael Millward	57
20	Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma 2014 ·BMC Cancer ·(unknown), Elin S. Gray, James Freeman, Anna Reid, Samantha Bowyer, Michael Millward, Mel Ziman	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact